- AdventHealth
Deep brain stimulation (DBS), a surgical procedure to help relieve symptoms of movement disorders such as Parkinson’s disease and dystonia, has improved the quality of life for some patients, easing motor symptoms and decreasing medication needs. Electrodes are implanted in a targeted area of the brain to deliver high-frequency electrical stimulation that helps regulate abnormal impulses as well as certain cells and chemicals. The amount of stimulation delivered is controlled by an impulse generator battery (IPG) that is implanted subcutaneously in the patient’s upper chest and connected to the electrodes in the brain. Until recently, patients had to come into a neurology clinic multiple times for adjustment of the device’s programming, especially in the first few months after surgical implantation. In 2021, AdventHealth became the first in Central Florida to offer the NeuroSphere Virtual Clinic, allowing DBS patients to receive their programming adjustments remotely via a telehealth appointment.
Approved by the U.S. Food and Drug Administration (FDA) in March 2021, the NeuroSphere Virtual Clinic provides patients the ability to connect to their physician through a secure patient controller app that includes video chat and integrated remote programming features. The physician can talk with the patient, observe symptoms and prescribe new treatment settings remotely to the patient's neurostimulation device using their clinician programmer app.
“With the NeuroSphere Virtual Clinic, we can provide the same, effective care to our patients in a secure way that is much more convenient for them,” explains Mitesh Lotia, MD, Movement Disorder Neurologist and Medical Director of the Movement Disorder Program at AdventHealth Neuroscience Institute. “Because DBS surgery is only available at larger medical centers, many patients travel several hours to receive treatment. Unfortunately, this can create a burden to accessing the ongoing follow-up care needed to properly regulate their device. Now we have eliminated this obstacle. Patients can receive their programming from the comfort of their home or office.”
AdventHealth offers DBS as a treatment option as appropriate for patients with the following conditions:
-
Parkinson's disease
-
Dystonia
-
Essential tremor
-
Epilepsy
Telehealth visits through the NeuroSphere Virtual Clinic are currently covered by Medicare and private insurances.
To learn more or refer a patient, click here.
Deep Brain Stimulation Treatment - The Ventriloquist
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...